Chinese Journal of Stroke ›› 2022, Vol. 17 ›› Issue (11): 1163-1170.DOI: 10.3969/j.issn.1673-5765.2022.11.002
Previous Articles Next Articles
YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun
Received:
2022-06-28
Online:
2022-11-20
Published:
2022-11-20
伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军
1 北京 100070 首都医科大学附属北京天坛医院神经病学中心
2 国家神经系统疾病临床医学研究中心
3 北京脑科学与类脑研究中心
4 国家神经系统疾病医疗质量控制中心
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
基金资助:
国家自然科学基金项目(82171270;92046016)
北京市自然科学基金项目(Z200016)
中国医学科学院医学与健康科技创新工程项目(2019-I2M-5-029)
YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170.
伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170.
[1] RADER D J,DAUGHERTY A. Translating molecular discoveries into new therapies for atherosclerosis[J]. Nature,2008,451(7181):904-913. [2] TABAS I,GARCÍA-CARDEÑA G,OWENS G K. Recent insights into the cellular biology of atherosclerosis[J]. J Cell Biol,2015,209(1):13-22. [3] VERGALLO R,CREA F. Atherosclerotic plaque healing[J]. N Engl J Med,2020,383(9):846-857. [4] KHYZHA N,ALIZADA A,WILSON M D,et al. Epigenetics of atherosclerosis:emerging mechanisms and methods[J]. Trends Mol Med,2017,23(4):332-347. [5] RIZZACASA B,AMATI F,ROMEO F,et al. Epigenetic modification in coronary atherosclerosis:JACC review topic of the week[J]. J Am Coll Cardiol,2019,74(10):1352-1365. [6] KHAN A W,PANENI F,JANDELEIT-DAHM K A M. Cell-specific epigenetic changes in atherosclerosis[J]. Clin Sci(Lond),2021,135(9):1165-1187. [7] NAPOLI C,PAOLISSO G,CASAMASSIMI A,et al. Effects of nitric oxide on cell proliferation:novel insights[J]. J Am Coll Cardiol,2013,62(2):89-95. [8] THIJSSEN D H J,BRUNO R M,VAN MIL A C C M,et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans[J]. Eur Heart J,2019,40(30):2534-2547. [9] LIBBY P. The changing landscape of atherosclerosis[J]. Nature,2021,592(7855):524-533. [10] DUNN J,QIU H,KIM S,et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis[J]. J Clin Invest,2014,124(7):3187-3199. [11] YANG Q,LI X H,LI R Q,et al. Low shear stress inhibited endothelial cell autophagy through TET2 downregulation[J]. Ann Biomed Eng,2016,44(7):2218-2227. [12] KU K H,DUBINSKY M K,SUKUMAR A N,et al. In vivo function of flow-responsive Cis-DNA elements of eNOS gene:a role for chromatin-based mechanisms[J]. Circulation,2021,144(5):365-381. [13] ZHANG Y P,HUANG Y T,HUANG T S,et al. The mammalian target of rapamycin and DNA methyltransferase 1 axis mediates vascular endothelial dysfunction in response to disturbed flow[J/OL]. Sci Rep,2017,7(1):14996[2022-06-16]. https://doi.org/10.1038/s41598-017-15387-5. [14] METHORST R,PASTERKAMP G,VAN DER LAAN S W. Exploring the causal inference of shear stress associated DNA methylation in carotid plaque on cardiovascular risk [J/OL]. Atherosclerosis,2021,325:30-37[2022-06-16]. https://doi.org/10.1016/j.atherosclerosis.2021.03.043. [15] JIANG Y Z,JIMÉNEZ J M,OU K,et al. Hemodynamic disturbed flow induces differential DNA methylation of endothelial kruppel-like factor 4 promoter in vitro and in vivo[J]. Circ Res,2014,115(1):32-43. [16] XIAO Y J,XIA J J,CHENG J Q,et al. Inhibition of S-adenosylhomocysteine hydrolase induces endothelial dysfunction via epigenetic regulation of p66shc-mediated oxidative stress pathway[J]. Circulation,2019,139(19):2260-2277. [17] LIU Y X,TIAN X X,LIU S,et al. DNA hypermethylation:a novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction[J/OL]. Redox Biol,2020,32:101444[2022-06-16]. https://doi.org/10.1016/j.redox.2020.101444. [18] BASATEMUR G L,JØRGENSEN H F,CLARKE M C H,et al. Vascular smooth muscle cells in atherosclerosis[J]. Nat Rev Cardiol,2019,16(12):727-744. [19] LIU R,JIN Y,TANG W H,et al. Ten-eleven translocation-2(TET2)is a master regulator of smooth muscle cell plasticity[J]. Circulation,2013,128(18):2047-2057. [20] SHANKMAN L S,GOMEZ D,CHEREPANOVA O A,et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis[J]. Nat Med,2015,21(6):628-637. [21] LACOLLEY P,REGNAULT V,SEGERS P,et al. Vascular smooth muscle cells and arterial stiffening:relevance in development,aging,and disease[J]. Physiol Rev,2017,97(4):1555-1617. [22] ZHUANG J H,LUAN P P,LI H L,et al. The yin-yang dynamics of DNA methylation is the key regulator for smooth muscle cell phenotype switch and vascular remodeling[J]. Arterioscler Thromb Vasc Biol,2017,37(1):84-97. [23] STRAND K A,LU S,MUTRYN M F,et al. High throughput screen identifies the DNMT1(DNA methyltransferase-1)inhibitor,5-azacytidine,as a potent inducer of PTEN(phosphatase and tensin homolog):central role for PTEN in 5-azacytidine protection against pathological vascular remodeling[J]. Arterioscler Thromb Vasc Biol,2020,40(8):1854-1869. [24] JEONG K,MURPHY J M,KIM J H,et al. FAK activation promotes SMC dedifferentiation via increased DNA methylation in contractile genes[J/OL]. Circ Res,2021,129(12):e215-e233[2022-06-16]. https://doi.org/10.1161/CIRCRESAHA.121.319066. [25] MOORE K J,SHEEDY F J,FISHER E A. Macrophages in atherosclerosis:a dynamic balance[J]. Nat Rev Immunol,2013,13(10):709-721. [26] KASIKARA C,DORAN A C,CAI B,et al. The role of non-resolving inflammation in atherosclerosis[J]. J Clin Invest,2018,128(7):2713-2723. [27] JIN F Y,LI J,GUO J F,et al. Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis[J/OL]. Eur Heart J Open,2021,1(2):oeab022[2022-06-16]. https://doi.org/10.1093/ehjopen/oeab022. [28] XIA Z Y,GU M L,JIA X D,et al. Integrated DNA methylation and gene expression analysis identifies SLAMF7 as a key regulator of atherosclerosis[J]. Aging(Albany NY),2018,10(6):1324-1337. [29] BARRETT T J. Macrophages in atherosclerosis regression[J]. Arterioscler Thromb Vasc Biol,2020,40(1):20-33. [30] YU J,QIU Y Z,YANG J,et al. DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice[J/OL]. Sci Rep,2016,6:30053[2022-06-16]. https://doi.org/10.1038/srep30053. [31] TANG R Z,ZHU J J,YANG F F,et al. DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis[J/OL]. J Mol Cell Cardiol,2019,128:11-24[2022-06-16]. https://doi.org/10.1016/j.yjmcc.2019.01.009. [32] FUSTER J J,MACLAUCHLAN S,ZURIAGA M A,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice[J]. Science,2017,355(6327):842-847. [33] ZHANG Y N,GUO Z Z,WU T W,et al. SULT2B1b inhibits reverse cholesterol transport and promotes cholesterol accumulation and inflammation in lymphocytes from AMI patients with low LDL-C levels[J]. Clin Sci(Lond),2020,134(2):273-287. [34] LIU Y,REYNOLDS L M,DING J,et al. Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis[J/OL]. Nat Commun,2017,8(1):393[2022-06-16]. https://doi.org/10.1038/s41467-017-00517-4. [35] XIANG Y,LIANG B,ZHANG X K,et al. Atheroprotective mechanism by which folic acid regulates monocyte subsets and function through DNA methylation[J/OL]. Clin Epigenetics,2022,14(1):32[2022-06-16]. https://doi.org/10.1186/s13148-022-01248-0. [36] DENG Q Y,HUANG W,PENG C Y,et al. Genomic 5-mC contents in peripheral blood leukocytes were independent protective factors for coronary artery disease with a specific profile in different leukocyte subtypes[J/OL]. Clin Epigenetics,2018,10:9[2022-06-16]. https://doi.org/10.1186/s13148-018-0443-x. [37] JIANG D,WANG Y,CHANG G L,et al. DNA hydroxymethylation combined with carotid plaques as a novel biomarker for coronary atherosclerosis[J]. Aging(Albany NY),2019,11(10):3170-3181. [38] JIANG D,SUN M,YOU L N,et al. DNA methylation and hydroxymethylation are associated with the degree of coronary atherosclerosis in elderly patients with coronary heart disease[J/OL]. Life Sci,2019,224:241-248[2022-06-16]. https://doi.org/10.1016/j.lfs.2019.03.021. [39] BAKSHI C,VIJAYVERGIYA R,DHAWAN V. Aberrant DNA methylation of M1-macrophage genes in coronary artery disease[J/OL]. Sci Rep,2019,9(1):1429[2022-06-16]. https://doi.org/10.1038/s41598-018-38040-1. [40] AMMOUS F,ZHAO W,LIN L,et al. Epigenetics of single-site and multi-site atherosclerosis in African Americans from the genetic epidemiology network of arteriopathy(GENOA)[J/OL]. Clin Epigenetics,2022,14(1):10[2022-06-16]. https://doi.org/10.1186/s13148-022-01229-3. [41] WU L P,PEI Y Q,ZHU Y H,et al. Association of N6-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts[J/OL]. Cell Death Dis,2019,10(12):909[2022-06-16]. https://doi.org/ 10.1038/s41419-019-2152-6. [42] ZUO H P,GUO Y Y,CHE L,et al. Hypomethylation of interleukin-6 promoter is associated with the risk of coronary heart disease[J]. Arq Bras Cardiol,2016,107(2):131-136. [43] HE X W,ZHAO Y,SHI Y H,et al. DNA methylation analysis identifies differentially methylated sites associated with early-onset intracranial atherosclerotic stenosis[J]. J Atheroscler Thromb,2020,27(1):71-99. [44] CULLELL N,SORIANO-TÁRRAGA C,GALLEGO-FÁBREGA C,et al. DNA methylation and ischemic stroke risk:an epigenome-wide association study[J]. Thromb Haemost,2022,122(10):1767-1778. [45] NAVAS-ACIEN A,DOMINGO-RELLOSO A,SUBEDI P,et al. Blood DNA methylation and incident coronary heart disease:evidence from the strong heart study[J]. JAMA Cardiol,2021,6(11):1237-1246. [46] FERNÁNDEZ-SANLÉS A,SAYOLS-BAIXERAS S,CURCIO S,et al. DNA methylation and age-independent cardiovascular risk,an epigenome-wide approach:the REGICOR study(registre gironí del COR)[J]. Arterioscler Thromb Vasc Biol,2018,38(3):645-652. [47] CASTELLANI C A,LONGCHAMPS R J,SUMPTER J A,et al. Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs[J/OL]. Genome Med,2020,12(1):84[2022-06-16]. https://doi.org/ 10.1186/s13073-020-00778-7. [48] PORTILLA-FERNÁNDEZ E,HWANG S J,WILSON R,et al. Meta-analysis of epigenome-wide association studies of carotid intima-media thickness[J]. Eur J Epidemiol,2021,36(11):1143-1155. [49] WEI L H,ZHAO S M,WANG G X,et al. SMAD7 methylation as a novel marker in atherosclerosis[J]. Biochem Biophys Res Commun,2018,496(2):700-705. [50] DEKKERS K F,VAN ITERSON M,SLIEKER R C,et al. Blood lipids influence DNA methylation in circulating cells[J/OL]. Genome Biol,2016,17(1):138[2022-06-16]. https://doi.org/10.1186/s13059-016-1000-6. [51] ADAMS H P JR,BENDIXEN B H,KAPPELLE L J,et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment[J]. Stroke,1993,24(1):35-41. [52] SORIANO-TÁRRAGA C,JIMÉNEZ-CONDE J,GIRALT-STEINHAUER E,et al. Global DNA methylation of ischemic stroke subtypes[J/OL]. PLoS One,2014,9(4):e96543[2022-06-16]. https://doi.org/10.1371/journal.pone.0096543. [53] SHEN Y P,PENG C,BAI Q K,et al. Epigenome-wide association study indicates hypomethylation of MTRNR2L8 in large-artery atherosclerosis stroke[J]. Stroke,2019,50(6):1330-1338. [54] KIM J Y,CHOI B G,JELINEK J,et al. Promoter methylation changes in ALOX12 and AIRE1:novel epigenetic markers for atherosclerosis[J/OL]. Clin Epigenetics,2020,12(1):66[2022-06-16]. https://doi.org/10.1186/s13148-020-00846-0. [55] BUSHUEVA O,BARYSHEVA E,MARKOV A,et al. DNA hypomethylation of the MPO gene in peripheral blood leukocytes is associated with cerebral stroke in the acute phase[J]. J Mol Neurosci,2021,71(9):1914-1932. [56] SORIANO-TÁRRAGA C,LAZCANO U,GIRALT-STEINHAUER E,et al. Identification of 20 novel loci associated with ischaemic stroke. Epigenome-wide association study[J]. Epigenetics,2020,15(9):988-997. [57] QIN X Y,LI J,WU T,et al. Overall and sex-specific associations between methylation of the ABCG1 and APOE genes and ischemic stroke or other atherosclerosis-related traits in a sibling study of Chinese population[J/OL]. Clin Epigenetics,2019,11(1):189[2022-06-16]. https://doi.org/10.1186/s13148-019-0784-0. [58] ZHANG H L,ZHAO X Y,WANG C J,et al. A preliminary study of the association between apolipoprotein E promoter methylation and atherosclerotic cerebral infarction[J]. J Stroke Cerebrovasc Dis,2019,28(4):1056-1061. [59] LI Z B,YU F,ZHOU X Q,et al. Promoter hypomethylation of microRNA223 gene is associated with atherosclerotic cerebral infarction[J/OL]. Atherosclerosis,2017,263:237-243[2022-06-16]. https://doi.org/10.1016/j.atherosclerosis.2017.06.924. [60] GALLEGO-FABREGA C,CULLELL N,SORIANO-TÁRRAGA C,et al. DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues[J]. Oncotarget,2020,11(10):905-912. [61] LI J J,ZHANG X P,YANG M X,et al. DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque[J/OL]. Clin Epigenetics,2021,13(1):161[2022-06-16]. https://doi.org/10.1186/s13148-021-01152-z. [62] GALLEGO-FABREGA C,CARRERA C,RENY J L,et al. PPM1A methylation is associated with vascular recurrence in aspirin-treated patients[J]. Stroke,2016,47(7):1926-1929. [63] GALLEGO-FABREGA C,CARRERA C,RENY J L,et al. TRAF3 epigenetic regulation is associated with vascular recurrence in patients with ischemic stroke[J]. Stroke,2016,47(5):1180-1186. [64] LI X G,ZHAO K,MA N,et al. Association of ABCB1 promoter methylation with aspirin exposure,platelet function,and clinical outcomes in Chinese intracranial artery stenosis patients[J]. Eur J Clin Pharmacol,2017,73(10):1261-1269. [65] LIBBY P,HANSSON G K. From focal lipid storage to systemic inflammation:JACC review topic of the week[J]. J Am Coll Cardiol,2019,74(12):1594-1607. |
[1] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[2] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[3] | YAN Ran, MIN Yan, QUAN Kehua, LI Zixiao. Relationship between BDNF and SLC6A4 Gene Methylation and the Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1178-1182. |
[4] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[5] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[6] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[7] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[8] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[9] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[10] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[11] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[12] | ZHANG Yige, ZHANG Wan, ZHANG Luyang, WANG Xin, DING Lan, WANG Yuying, PEI Lulu, FANG Hui, XU Yuming, SONG Bo. Association of Artery Occlusion and Recurrent Ischemic Stroke Related with Cerebral Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(09): 932-936. |
[13] | LYU Wei, WANG Anxin, TIAN Xue, ZHANG Xiaoli, XU Yuyuan, MENG Xia. Effect of Xinxuening Capsule on Short-term Functional Outcome in Patients with Ischemic Stroke and High Homocysteine Level [J]. Chinese Journal of Stroke, 2022, 17(09): 972-976. |
[14] | ZHANG Xinmiao, PAN Yuesong, XIANG Xianglong, WANG Yongjun, MENG Xia. Early Clinical Pathway Intervention to Improve the Key Performance Indicators of Medical Care for Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 977-984. |
[15] | GONG Yutian, LI Jiejie. Advances in the Relationship between IL-6 and Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 1022-1026. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||